US Stocks
/
Viking Therapeutics, Inc. Share Price
Viking Therapeutics, Inc. Share Price

Viking Therapeutics, Inc. Share Price

NASDAQ: VKTX | Mid Cap
$27.73
-$0.84 (-2.92%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Viking Therapeutics, Inc. Stock Performance

Open
$28.26
Prev. Close
$28.57
Circuit Range
N/A
Day Range
$27.06 - $28.42
Year Range
$25.77 - $43.08
Volume
2,59,067
Average Traded
$27.50

Viking Therapeutics, Inc. Share Price Today

As of 9 October 2026, Viking Therapeutics, Inc.'s share price is $27.73. The stock opened at $28.26, compared to its previous close of $28.57. During today's trading session, Viking Therapeutics, Inc.'s share price traded between $27.06 and $28.42, with an average price of $27.74. Over the past 52 weeks, the stock has recorded a high of $43.08 and a low of $25.77. In terms of performance, Viking Therapeutics, Inc.'s share price has declined by 10.92% over the last six months and is down 27.28% on a year-on-year basis.

Viking Therapeutics, Inc. Share Price Chart

$27.06$28.42
L
Show Current Price
H

Viking Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.12B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.21
Revenue (TTM)
$0.00
Return On Equity (TTM)
-130.98%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-41.01%

Viking Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$90.79-$157.66-$158.33-$128.02
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-73.65%-0.42%19.14%

Viking Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$68.87-$85.90-$109.96-$359.64
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-24.73%-28.01%-227.06%

About Viking Therapeutics, Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Viking Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$31.95
$27.75
-14.96%
Sep 2026
$33.08
$32.63
-3.76%
Aug 2026
$31.43
$33.91
+6.75%
Jul 2026
$39.44
$31.76
-18.62%
Jun 2026
$32.22
$39.02
+19.29%
May 2026
$31.31
$32.72
+5.09%
Apr 2026
$32.80
$31.13
-4.33%
Mar 2026
$33.15
$32.54
-3.98%
Feb 2026
$28.65
$33.89
+16.64%
Jan 2026
$35.53
$29.05
-17.39%
Dec 2025
$36.14
$35.17
-4.46%
Nov 2025
$38.23
$36.81
-3.46%

VKTX Share Price FAQs

What is Viking Therapeutics, Inc. share price today?

chevron-up
Viking Therapeutics, Inc. share price today is $27.73 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Viking Therapeutics, Inc. stock?

chevron-up
The 52 week high of Viking Therapeutics, Inc. stock is $43.08, while the 52 week low is $25.77 as of 9 Oct '26.

What is VKTX's market capitalisation today?

chevron-up
VKTX market capitalisation is $3.12B as of October 9, 2026, at 4:46 pm IST.

What is VKTX's net income for the last quarter?

chevron-up
VKTX's net income for the last quarter is -128.02B USD.

What is the 5 year returns of VKTX?

chevron-up
The 5 year returns of VKTX is 376.46% as on 9 Oct '26.

What is the high & low stock price of VKTX today?

chevron-up
VKTX stock price hit a high of $28.42 and low of $27.06 as of 9 Oct '26.

Can I buy VKTX shares in India?

chevron-up
Yes. You can buy VKTX in India by opening an international trading account.